Showing results (341-350 of 1,551) with videos related to

Sort By:
Pageof 156
JCO Oncology Practice|January 11, 2024
Using Implementation Science Frameworks to Guide the Use of Electronic Patient-Reported Outcome Symptom Monitoring in Routine Cancer CareJulia Lai-Kwon, Claudia Rutherford, Michael Jefford, et al.
JCO Oncology Practice|June 18, 2026
Maintenance Pemetrexed/Pembrolizumab Versus Pembrolizumab in Non-Small Cell Lung Cancer: A Propensity Score-Weighted AnalysisGarth W Strohbehn, Molly C Tokaz, Daniel Sanghoon Shin, et al.
JCO Oncology Practice|June 17, 2026
Practical Management of Bispecific Antibodies in Multiple MyelomaCarlyn Rose Tan, Neha Korde, Hira Mian
JCO Oncology Practice|June 17, 2026
Patient Perspectives on and Willingness to Pay for Navigation Services Billed Under Centers for Medicare & Medicaid Services Principal Illness Navigation CodesCourtney P Williams, Jessica Shuey, Nicole L Henderson, et al.
JCO Oncology Practice|July 1, 2026
Implementation and Patient-Reported Outcomes of an Insurance-Supported Integrative Oncology Symptom Management ProgramMeha Srivastava, Samuel N Rodgers-Melnick, Jacob Wolf, et al.
JCO Oncology Practice|July 6, 2026
Acupuncture in Cancer Care: Evidence, Safety, and Implementation in Oncology PracticeWeidong Lu, Eunbin Kwag, Irene Martyniuk, et al.
JCO Oncology Practice|July 6, 2026
Evaluation of the Feasibility and Safety of Ifosfamide-Based Chemotherapy Regimens for Sarcomas in the Outpatient SettingMina Seo, Firas Hatoum, Jennifer Swank, et al.
JCO Oncology Practice|July 7, 2026
Availability and Use of Social Determinants of Health Data in Alliance Gastrointestinal Cancer Clinical TrialsKever A Lewis, Brian A Colgrove, Garth D Nelson, et al.
JCO Oncology Practice|July 7, 2026
Adoption of Bevacizumab Biosimilars in Medicare Part B: Socioeconomic and Geographic Variation, 2019-2023Taemin Kim, Michael Sheen, Andrew Yang, et al.
JCO Oncology Practice|July 8, 2026
Real-World Implementation of Tarlatamab-Dlle Therapy for Patients With Extensive-Stage Small Cell Lung Cancer and Other High-Grade Neuroendocrine NeoplasmsJennifer W Carlisle, Katherine O'Reilly, Xiyuan Angel Ji, et al.
Pageof 156